EPIX Essa Pharma Inc
Price (delayed)
$1.68
Market cap
$74.57M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.64
Enterprise value
-$29.06M
as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in
Highlights
The company's debt fell by 3.8% QoQ
EPIX's quick ratio is down by 9% year-on-year but it is up by 5% since the previous quarter
EPIX's equity is down by 14% year-on-year and by 3.3% since the previous quarter
The net income has contracted by 7% YoY and by 3.2% from the previous quarter
Key stats
What are the main financial stats of EPIX
Market
Valuations
Earnings
Shares outstanding
44.39M
Market cap
$74.57M
Enterprise value
-$29.06M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.6
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$34.42M
Net income
-$28.54M
EBIT
-$28.54M
EBITDA
-$28.45M
Free cash flow
-$22.72M
Per share
Balance sheet
Liquidity
EPS
-$0.64
EPS diluted
-$0.64
Free cash flow per share
-$0.51
Book value per share
$2.81
Revenue per share
$0
TBVPS
$2.89
Total assets
$128.11M
Total liabilities
$3.51M
Debt
$329,260
Equity
$124.61M
Working capital
$124.26M
Debt to equity
0
Current ratio
38.64
Quick ratio
38.53
Net debt/EBITDA
3.64
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-21%
Return on equity
-21.6%
Return on invested capital
-53.8%
Return on capital employed
-22.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EPIX stock price
How has the Essa Pharma stock price performed over time
Intraday
-0.59%
1 week
-3.72%
1 month
-9.68%
1 year
-82.57%
YTD
-6.15%
QTD
-6.15%
Financial performance
How have Essa Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$34.42M
Net income
-$28.54M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 7% YoY and by 3.2% from the previous quarter
EPIX's operating income is down by 7% year-on-year
Growth
What is Essa Pharma's growth rate over time
Valuation
What is Essa Pharma stock price valuation
P/E
N/A
P/B
0.6
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has decreased by 7% YoY and by 3.2% QoQ
The stock's price to book (P/B) is 74% less than its 5-year quarterly average of 2.3 and 73% less than its last 4 quarters average of 2.2
EPIX's equity is down by 14% year-on-year and by 3.3% since the previous quarter
Efficiency
How efficient is Essa Pharma business performance
EPIX's return on invested capital has dropped by 126% year-on-year and by 47% since the previous quarter
EPIX's ROE is down by 25% YoY and by 7% from the previous quarter
EPIX's return on assets is down by 24% year-on-year and by 7% since the previous quarter
Dividends
What is EPIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EPIX.
Financial health
How did Essa Pharma financials performed over time
EPIX's total assets is down by 14% year-on-year and by 3.4% since the previous quarter
The company's current ratio fell by 9% YoY but it rose by 4.6% QoQ
The company's debt is 100% lower than its equity
EPIX's equity is down by 14% year-on-year and by 3.3% since the previous quarter
The company's debt fell by 3.8% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.